INSITE VISION INC 4
4 · INSITE VISION INC · Filed Oct 30, 2015
Insider Transaction Report
Form 4
Patel Surendra
VP, Operations & Quality
Transactions
- Disposition from Tender
Common Stock
2015-10-28$0.35/sh−6,323$2,213→ 16,665 total
Footnotes (1)
- [F1]On October 28, 2015, Thea Acquisition Corp, ("Purchaser"), a wholly owned subsidiary of Ranbaxy, Inc. ("Ranbaxy"), which is an indirect wholly owned subsidiary of Sun Pharmaceutical Industries Ltd., completed a tender offer for all the outstanding shares of InSite Vision Incorporated ("Issuer") for a purchase price of $0.35 per share, all pursuant to that certain Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Purchaser, Ranbaxy and Issuer.